8 March 2021 - A new and potentially curative one-off gene therapy for babies with the rare genetic disorder spinal muscular ...
26 February 2021 - Another potentially life-extending drug combination for some people with advanced breast cancer will now be available for ...
25 February 2021 - The first and only anti-CGRP treatment with dual indications. ...
25 February 2021 - BioCryst Pharmaceuticals today announced that the CHMP of the EMA has adopted a positive opinion recommending ...
25 February 2021 - Medexus Pharmaceuticals announced today that it has initiated the commercial launch of Gleolan in Canada, which had ...
25 February 2021 - The LimiFlex Paraspinous Tension Band is a new, investigational device designed as an alternative to spinal fusion ...
25 February 2021 - RT001 also granted fast track designation by FDA in Friedreich’s ataxia. ...
25 February 2021 - NICE has agreed a managed access agreement, via the Cancer Drugs Fund with manufacturer Kite, so more ...
25 February 2021 - If approved, this is expected to be the first eye drop to treat presbyopia. ...
25 February 2021 - Exelixis expects to submit supplementary New Drug Application in 2021. ...
25 February 2021 - Today, the U.S. FDA granted approval for Amondys 45 (casimersen) injection for the treatment of Duchenne muscular ...
25 February 2021 - NICE has today issued draft guidance for public consultation which recommends sapropterin (Kuvan, BioMarin) for treating phenylketonuria ...
25 February 2021 - EMA has issued guidance outlining the requirements for manufacturers planning to modify their COVID-19 vaccines in ...
25 February 2021 - Regulators around the globe are committed to aligning their regulatory requirements and addressing knowledge gaps to facilitate ...
24 February 2021 - Australians are being forced to take desperate measures to track down prescription medications they need as ...
24 February 2021 - Drug developers see FDA approval as a difficult uphill climb, requiring large investments of resources and ...